tarSys™

Eye surgery requires precise micro surgical materials and techniques. IOP, Inc. has licensed SIS technology to develop and market applications for use in ophthalmic surgery. tarSys™ is the first SIS-derived device designed specifically for eyelid reconstruction.

For more information on ophthalmic uses of SIS,
visit IOP inc.

Please Select a Body System

NOTE: Any medical device has the potential for complications. Please consult product labels and inserts for indications, contraindications, hazards, warnings, precautions, and instructions for use. Potential complications with use of a biologic graft may include bleeding, infection, abscess, induration, acute or chronic inflammation (initial use of biologic graft materials may be associated with transient, mild, localized inflammation), allergic reaction, visceral adhesions, fistula formation, seroma formation, hematoma, extrusion, recurrence of tissue defect, and delayed or failed incorporation of the device.